Home › Funds › NEA Management Company, LLC › ZBIO
NEA Management Company, LLC position in ZBIO
ZENAS BIOPHARMA INC COM · Health Care
NEA Management Company, LLC reported holding 4,023,219 shares of ZBIO (ZENAS BIOPHARMA INC COM) in its Q2 2026 13F filing — a position valued at US$102.1M, representing 6.43% of its reported portfolio and ranking #7 among its reported holdings. NEA Management Company, LLC has disclosed ZBIO holdings in 8 of the last 8 reported quarters, going back to Q3 2024.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How NEA Management Company, LLC's ZBIO position evolved
NEA Management Company, LLC first disclosed a stake in ZBIO in Q3 2024 at 2,613,948 shares (US$44.2M). The position peaked in Q4 2025 at 3,523,219 shares, worth US$127.9M. Across 8 filings, NEA Management Company, LLC increased the stake 3 time(s), trimmed it 0 time(s) and left it unchanged 4 time(s). The most recent filing (Q2 2026) shows 4,023,219 shares valued at US$102.1M. Notable position changes include a 29% increase in Q4 2025 (shares fell 46% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2024 | 2.61M | $44.23M | New |
| Q4 2024 | 2.61M | $21.41M | Hold |
| Q1 2025 | 2.61M | $20.65M | Hold |
| Q2 2025 | 2.73M | $26.49M | Add |
| Q3 2025 | 2.73M | $60.69M | Hold |
| Q4 2025 | 3.52M | $127.93M | Add |
| Q1 2026 | 4.02M | $78.65M | Add |
| Q2 2026 | 4.02M | $102.11M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ZBIO and 13F data
ZBIO (ZENAS BIOPHARMA INC COM) is a Health Care company. 68 other funds we track also report a position in ZBIO — the largest reported positions include SR ONE CAPITAL MANAGEMENT, LP (US$127.9M), Enavate Sciences GP, LLC (US$99.5M), DEERFIELD MANAGEMENT COMPANY, L.P. (US$80.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ZBIO
- SR ONE CAPITAL MANAGEMENT, LP 5.04M sh · $127.86M · Q2 2026
- Enavate Sciences GP, LLC 3.92M sh · $99.47M · Q2 2026
- DEERFIELD MANAGEMENT COMPANY, L.P. 67.20M sh · $80.32M · Q2 2026
- Royalty Pharma Sub-Manager, LLC 2.39M sh · $60.61M · Q2 2026
- Fairmount Funds Management LLC 2.36M sh · $59.87M · Q2 2026
- NVP Associates, LLC 1.84M sh · $46.66M · Q2 2026
- Context Capital Management, LLC 35.80M sh · $42.60M · Q2 2026
- EcoR1 Capital, LLC 789.50K sh · $20.04M · Q2 2026
- ArrowMark Colorado Holdings LLC 573.32K sh · $14.55M · Q2 2026
- SILVERARC CAPITAL MANAGEMENT, LLC 509.79K sh · $12.94M · Q2 2026
- Rock Springs Capital Management LP 502.08K sh · $12.74M · Q2 2026
- Pivotal bioVenture Partners Investment Advisor LLC 490.77K sh · $12.46M · Q2 2026
More on NEA Management Company, LLC
FAQ
How long has NEA Management Company, LLC held ZBIO?
NEA Management Company, LLC has disclosed ZBIO holdings in 8 of the last 8 reported quarters, going back to Q3 2024.
What is NEA Management Company, LLC's current position in ZBIO?
As of Q2 2026, NEA Management Company, LLC holds 4.02M shares of ZBIO (ZENAS BIOPHARMA INC COM), valued at $102.11M, representing 6.43% of its reported portfolio and ranking #7.
Has NEA Management Company, LLC been buying or selling ZBIO?
In the latest 13F filing (Q2 2026), NEA Management Company, LLC held unchanged its position in ZBIO. The position peaked in Q4 2025 at 3.52M shares.
Which other funds hold ZBIO?
Other major institutional holders of ZBIO include SR ONE CAPITAL MANAGEMENT, LP, Enavate Sciences GP, LLC, DEERFIELD MANAGEMENT COMPANY, L.P., among 68 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.